Search

everythinglearnresearchcommunity

for

Search:↓

Activating a bitter taste receptor in hair follicles can stop hair growth by increasing a specific growth factor.

Lipocalin-Type Prostaglandin D2 Synthase (L-PGDS) is a protein that plays many roles in the body, including sleep regulation, pain management, food intake, and protection against harmful substances. It also affects fat metabolism, glucose intolerance, cell maturation, and is involved in various diseases like diabetes, cancer, and arthritis. It can influence sex organ development and embryonic cell differentiation, and its levels can be used as a diagnostic marker for certain conditions.

The document concludes that adenosine receptor agonists have potential for treating various conditions, but only a few are approved due to challenges like side effects and the need for selective activation.

Formyl-peptide receptor agonists could be new anti-inflammatory drugs.

Cannabinoid and steroid-based drugs could be new treatments for Tourette syndrome, but more research is needed to confirm their effectiveness and safety.

Sacituzumab tirumotecan shows promise in treating breast cancer with manageable side effects.

TAK-279 effectively reduces psoriasis symptoms and is safe.

Fesoterodine is effective and safe for elderly patients with overactive bladder.

Testosterone reduces knee movement, while flutamide and finasteride increase it.

TRPA1 and TRPV1 channels don't affect mechanotransduction in rat sinus hair follicles.

Combination therapy with fesoterodine and doxazosin improves bladder function and delays BPH progression.

14,15-EET may help reduce poststroke pain by affecting certain brain proteins.

Tolterodine Tartrate effectively treats overactive bladder symptoms.

Isoallopregnanolone may be a safe and effective treatment for reducing tics in a mouse model of Tourette syndrome.

Therapies targeting the androgen receptor are being developed to treat prostate cancer and improve bone and muscle health.

TLR-targeted therapies show promise in cancer treatment by helping destroy tumors.

New androgen receptor modulators show promise for treating diseases like prostate cancer and muscle wasting.

The combination of tadalafil and finasteride improves urinary symptoms and erectile function in men with enlarged prostates.

Two new compounds were found to build bone and muscle without affecting reproductive organs and skin oil glands.

Selective androgen receptor modulators (SARMs) are a promising type of drug for various health conditions due to their targeted actions.

Compounds 15, 20, and 25 are strong inhibitors of human steroid 5α-reductase type 2.

The compound GD-23 may reduce anxiety like diazepam by targeting the TSPO receptor.

New compounds show promise for treating benign prostate hyperplasia with fewer side effects.

Targeting 5α-reductase type 1 may help manage Tourette-like symptoms.

The conclusion is that a new test was created to find substances that affect specific ion channels, and it works well for drug discovery.

Targeting the MC-5-HT-HTR2A axis may help treat chronic itching.

New nonsteroidal molecules can potentially increase dihydrotestosterone in neurons by blocking certain enzymes, without affecting prostate and seminal vesicle weight.

Two new compounds can block androgen receptor activity in different ways and may lead to new treatments for androgen-related diseases.

Current treatments for lower urinary tract symptoms include α1-blockers, 5ARIs, PDE5 inhibitors, anticholinergic agents, and β3-adrenergic receptor agonists.

Certain drugs can reduce bladder muscle contractions, potentially helping treat bladder diseases.